CLEC-2/podoplanin and thromboinflammation.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

12 citing papers in PubMed.

1. Inhibition of SARS-CoV-2-mediated thromboinflammation by CLEC2.Fc.EMBO molecular medicine · 2023
   Article
2. Podoplanin: Its roles and functions in neurological diseases and brain cancers.Frontiers in pharmacology · 2022
   Review
3. The Role of CLEC-2 and Its Ligands in Thromboinflammation.Frontiers in immunology · 2021
   Review
4. Interplay between Podoplanin, CD44s and CD44v in Squamous Carcinoma Cells.Cells · 2020
   Article
5. Pulmonary embolism: A warning sign of occult malignancy.Journal of the Chinese Medical Association : JCMA · 2020
   Article
6. Neoadjuvant chemoradiation changes podoplanin expression in esophageal cancer patients.World journal of gastroenterology · 2020
   Article
7. Plasma soluble C-type lectin-like receptor-2 is associated with the risk of coronary artery disease.Frontiers of medicine · 2020
   Article
8. Understanding Inflammatory Responses in the Manifestation of Prothrombotic Phenotypes.Frontiers in cell and developmental biology · 2020
   Review
9. Platelets and cancer-associated thrombosis: focusing on the platelet activation receptor CLEC-2 and podoplanin.Hematology. American Society of Hematology. Education Program · 2019
   Review
10. Podoplanin regulates the migration of mesenchymal stromal cells and their interaction with platelets.Journal of cell science · 2019
    Article
11. Signaling Pathways of Receptors Involved in Platelet Activation and Shedding of These Receptors in Stored Platelets.Advanced pharmaceutical bulletin · 2019
    Review
12. Elevated Soluble Podoplanin Associates with Hypercoagulability in Patients with Nephrotic Syndrome.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
    Article

Corrections and comments

• Comment on
  Mice with a deficiency in CLEC-2 are protected against deep vein thrombosis.2017

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as